about
DLQI scores in vitiligo: reliability and validity of the Persian versionWhy quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of Life.The impact of patients' chronic disease on family quality of life: an experience from 26 specialtiesThe Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results.A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases.New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group.Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.Does smoking influence acne?Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life.European evidence-based (S3) guidelines for the treatment of acne.Staphylococcal scalded skin syndrome: diagnosis and management.The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countriesCurrent thinking in atopic eczema.10 years experience of the Dermatology Life Quality Index (DLQI).Current severe psoriasis and the rule of tens.A critical review of Quality-of-Life Scales for Psoriasis.Skin disease in the elderly.Impact of skin diseases on quality of life.The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis.Psoriasis: improving adherence to topical therapy.Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.Understanding clinician influences and patient perspectives on outpatient discharge decisions: a qualitative study.The role of the EQ-5D in the economic evaluation of dermatological conditions and therapies.Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012.Concept of major life-changing decisions in life course research.Infants' Dermatitis Quality of Life Index: a decade of experience of validation and clinical application.The dermatology outpatient discharge decision: understanding a critical but neglected process.Global overview of Lamisil.Conceptualisation, development and validation of T-QoL© (Teenagers' Quality of Life): a patient-focused measure to assess quality of life of adolescents with skin diseases.Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression.A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.Broader concepts of quality of life measurement, encompassing validation.Dermatology outpatient case-mix survey for all Welsh Trusts, 2007.Quality of Life Measurement in Acne. Position Paper of the European Academy of Dermatology and Venereology (EADV) Task Forces on Quality of Life and Patient Oriented Outcomes (QoL and PO) and Acne, Rosacea and Hidradenitis Suppurativa (ARHS).Psoriasis has a major secondary impact on the lives of family members and partners.Comparison of the paper-based and electronic versions of the Dermatology Life Quality Index: evidence of equivalence.Dermatology examination performance: wide variation between different teaching centres.Disability and handicap in dermatology.Measurement of disease activity and outcome in atopic dermatitis.Quality of life measurement in dermatology: a practical guide.
P50
Q24801871-8CC1899F-EE43-4B05-BACD-13AD9A15C57AQ30244189-326E857B-1126-4383-8EA4-FC01AABDBBD9Q30547808-9BFE24EA-984A-4358-9521-C0D2D7CC880BQ33369928-3A44008C-B42F-4A44-AEDC-A3AD245EB20CQ33402382-61B4160C-7568-4B03-8697-3133C0F48BA7Q33431703-344377AB-4C79-4943-BBAD-1CC257A1EE68Q34209858-148CDD6C-780F-4D34-BDD1-E8A8E469807DQ34364069-D62083A6-96C1-484F-B128-7BB237CADA04Q34570026-FACE6546-E5C8-4500-BF8E-CA5BCAB8EE9EQ34636056-88C0E4D9-E958-4ACF-A261-072628F5E786Q35081977-51FE00FA-EE2E-464C-BE3E-9577DA074079Q35228919-A4E79579-26A2-47DF-8EF8-3B6C8C72F3A2Q35570610-B5442B0A-170E-442A-9E12-F6225092CC91Q35745472-D81777EF-73FB-43A5-88A5-41C5450E8A39Q36124195-7604A881-5881-43E2-87AF-37853861D221Q36236264-9B5A4D9A-14B9-4377-B335-D45E0F9D8914Q36541809-818785B5-D521-45F9-9B8B-C76464DCAFC9Q36746047-F0A32DD6-C299-4411-A0BC-F30A63EF325AQ36771864-7FA09275-19F5-43F5-8A4A-39567385EDB7Q37286486-E75664A9-8CD9-479E-9413-6D48972D538DQ37505028-DE369375-79E7-4E90-A086-8DA0CE3FCC86Q37704291-19F0F881-CFA0-4FEE-B760-CB32C45BCD39Q38038057-2F7C6E30-558B-491A-9BFD-1CC835A04009Q38107270-DEA3E15A-6FEE-4AEA-B070-8CC93080BF8CQ38116680-2752C6A3-CBFC-46D2-958B-24205C2A9693Q38126112-B8F04C91-735A-43D8-980F-168A92B4935BQ38176933-8FB0A31F-4FE2-48DD-9A6D-9BDDD7BAD51EQ38568534-A3AFDD33-1FBB-4655-A561-36B290480EDBQ38649988-E2C4DEB5-2C28-4BEA-82F8-55569A5AF991Q38732025-147DFDBE-7274-4C10-926C-6D1FF5AC9863Q38858335-CF909854-6353-4F99-8525-334857FA0686Q39215992-1785C20A-49F2-46E4-9915-AB1206AB0C72Q39942522-7E7D2EA8-261E-4811-B797-F41A4D5195C7Q40045486-2347C5D7-83F1-44CC-9A58-F97663EE4C4EQ40219748-ECD90FD2-488B-46E2-99A6-06543EA99ECAQ40361911-6B29C8F6-D79A-4397-931A-86DCF6C48ED5Q41029177-4377D25D-4128-40E8-B43E-0FA0BD443FB3Q41058788-D7F790FD-F648-4C7F-8025-7FF60F62F3FDQ41208106-CAA630B2-5F74-4A9E-AFB6-77225E3E6D36Q41442406-5D551DAB-816B-4CBA-8E9F-D3D9022D2519
P50
description
dermatologist
@en
dermatoloog
@nl
name
A Y Finlay
@nl
Andrew Y. Finlay
@en
Andrew Y. Finlay
@es
type
label
A Y Finlay
@nl
Andrew Y. Finlay
@en
Andrew Y. Finlay
@es
altLabel
A Finlay
@en
A Y Finlay
@en
Andrew Finlay
@en
Finlay A
@en
Finlay AY
@en
prefLabel
A Y Finlay
@nl
Andrew Y. Finlay
@en
Andrew Y. Finlay
@es
P106
P21
P31
P496
0000-0003-2143-1646